Citation Impact
Citing Papers
Pain Syndromes in Patients with Cancer
1987
Molecular biology and genetics of prion diseases
1994 StandoutNobel
Acromegaly
2006 Standout
Effectiveness of cabergoline in monotherapy and combined with ketoconazole in the management of Cushing’s disease
2009
Management of cancer pain
1999 Standout
Variant Alzheimer Disease With Spastic paraparesis: Neuropathological phenotype
2001
Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial
2006 Standout
Deciphering the Molecular Basis of Memory Failure in Alzheimer's Disease
2004
Familial Creutzfeldt-Jakob disease in Chile is associated with the codon 200 mutation of the PRNP amyloid precursor gene on chromosome 20
1992 Nobel
Improving diagnostic accuracy and interobserver concordance in the classification and grading of primary gliomas
1997
Nature, Nurture, or Chance: Stochastic Gene Expression and Its Consequences
2008 Standout
Linkage of the Indiana kindred of Gerstmann-Sträussler-Scheinker disease to the prion protein gene
1992 StandoutNobel
Cushing's Syndrome Due to Primary Multinodular Corticotrope Hyperplasia
1988
Molecular Advances in Understanding Inherited Prion Diseases
2002
Cushing's syndrome
2015 Standout
Oligodendroglioma: An Appraisal of Recent Data Pertaining to Diagnosis and Treatment
1999
Treatment of single brain metastasis: Radiotherapy alone or combined with neurosurgery
1993
Transsphenoidal Microsurgery for Cushing Disease
1988
GLIOMA EXTENT OF RESECTION AND ITS IMPACT ON PATIENT OUTCOME
2008
Acromegaly
1990
A BROMOCRIPTINE‐RESPONSIVE CORTICOTROPH ADENOMA SECRETING α‐MSH IN A PATIENT WITH CUSHING'S DISEASE
1988
Fatal Familial Insomnia, a Prion Disease with a Mutation at Codon 178 of the Prion Protein Gene
1992
Photodynamic therapy for cancer
2003 Standout
The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary
2016 Standout
Molecular properties of complexes formed between the prion protein and synthetic peptides
1997 StandoutNobel
Prion Protein Isoforms, a Convergence of Biological and Structural Investigations
1995 StandoutNobel
Spontaneous generation of infectious nucleating amyloids in the transmissible and nontransmissible cerebral amyloidoses
1994 Nobel
Octreotide
1996
MEDICAL THERAPY FOR CUSHING'S DISEASE
1999
Stroke
2008 Standout
Glial and neuronal control of brain blood flow
2010 StandoutNature
EXTENT OF RESECTION AND SURVIVAL IN GLIOBLASTOMA MULTIFORME
2008
CNS stem cells express a new class of intermediate filament protein
1990 Standout
Phenotypic characteristics of familial Creutzfeldt‐Jakob disease assoicated with the codon 178AsnPRNP mutation
1992
Malignant Gliomas in Adults
2008 Standout
The transmissible amyloidoses: Genetical control of spontaneous generation of infectious amyloid proteins by nucleation of configurational change in host precursors: Kuru-CJD-GSS-Scrapie-BSE
1991 Nobel
Alzheimer's disease
2006 Standout
Meningioma Grading
1997
Pain and Its Treatment in Outpatients with Metastatic Cancer
1994 Standout
In vitro and in vivo evaluation of 64Cu-TETA-Tyr3-octreotate. a new somatostatin analog with improved target tissue uptake
1999
Fatal Familial Insomnia and Familial Creutzfeldt‐Jakob Disease: Clinical, Pathological and Molecular Features
1995
Limitations of stereotactic biopsy in the initial management ofgliomas
2001
Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma
2005 Standout
Cushing's syndrome in pregnancy treated by ketoconazole: Case report and review of the literature
1999
Clinicopathologic study of 85 similarly treated patients with anaplastic astrocytic tumors
1999
Primary brain tumours in adults
2012 Standout
Subarachnoid haemorrhage: diagnosis, causes and management
2001
Stereotactic Radiosurgery Plus Whole-Brain Radiation Therapy vs Stereotactic Radiosurgery Alone for Treatment of Brain Metastases
2006 Standout
Subarachnoid haemorrhage
2007 Standout
Magnesium Sulfate in Aneurysmal Subarachnoid Hemorrhage
2005
Cushing's syndrome and pregnancy
1990
Extent of Resection in Malignant Gliomas: a Critical Summary
1999
TRANSSPHENOIDAL SURGERY FOR CUSHING'S DISEASE: DOES WHAT IS REMOVED DETERMINE THE ENDOCRINE OUTCOME?
1990
Influence of location and extent of surgical resection on survival of patients with glioblastoma multiforme: Results of three consecutive radiation therapy oncology group (RTOG) clinical trials
1993
Insoluble wild–type and protease–resistant mutant prion protein in brains of patients with inherited prion disease
1996 StandoutNobel
Histopathological-Molecular Genetic Correlations in Referral Pathologist-Diagnosed Low-Grade “Oligodendroglioma”
2002
Cytoreductive surgery of glioblastoma as the key to successful adjuvant therapies: new arguments in an old discussion
2011
Fluorescence-guided resection of glioblastoma multiforme utilizing 5-ALA-induced porphyrins: a prospective study in 52 consecutive patients
2000
Somatostatin receptor (SSTR) subtype-selective analogues differentially suppress in vitro growth hormone and prolactin in human pituitary adenomas. Novel potential therapy for functional pituitary tumors.
1997
Creutzfeldt‐Jakob disease cosegregates with the codon 178AsnPRNP mutation in families of European origin
1992 Nobel
Octreotide in the Management of Hormone-Refractory Prostate Cancer
2001
The Brain's Default Network
2008 Standout
Brain Tumors
2001 Standout
Mice devoid of PrP are resistant to scrapie
1993 Standout
Delayed ischaemic neurological deficits after subarachnoid haemorrhage are associated with clusters of spreading depolarizations
2006
Identification of a prion protein epitope modulating transmission of bovine spongiform encephalopathy prions to transgenic mice
1997 StandoutNobel
Surgical Remission of Pituitary Adenomas Confined to the Neurohypophysis in Cushing’s Disease
2006
Coordinating Radiometals of Copper, Gallium, Indium, Yttrium, and Zirconium for PET and SPECT Imaging of Disease
2010 Standout
Beneficial Effects of High Daily Dose Bromocriptine Treatment in Cushing's Disease.
1992
Primitive neuroectodermal tumors of the central nervous system
1983
Prion protein NMR structure and familial human spongiform encephalopathies
1998 StandoutNobel
Chemical chaperones interfere with the formation of scrapie prion protein.
1996 StandoutNobel
Supramolecular Hydrogelators and Hydrogels: From Soft Matter to Molecular Biomaterials
2015 Standout
Management problems in acute hydrocephalus after subarachnoid hemorrhage.
1989
Diagnostic Evaluation of Cushing’s Syndrome
1988
The Amyloid Hypothesis of Alzheimer's Disease: Progress and Problems on the Road to Therapeutics
2002 StandoutScience
Evidence for Two Subtypes of Cushing's Disease Based on the Analysis of Episodic Cortisol Secretion
1985
Memory--a Century of Consolidation
2000 StandoutScience
Rebleeding, secondary ischemia, and timing of operation in patients with subarachnoid hemorrhage
2000
Physical Studies of Conformational Plasticity in a Recombinant Prion Protein
1997 StandoutNobel
Proposed three-dimensional structure for the cellular prion protein.
1994 StandoutNobel
Patterns of Cerebral Infarction in Aneurysmal Subarachnoid Hemorrhage
2005
Copper Homeostasis and Neurodegenerative Disorders (Alzheimer's, Prion, and Parkinson's Diseases and Amyotrophic Lateral Sclerosis)
2006 Standout
Dynamic Changes in Prolactin Promoter Activation in Individual Living Lactotrophic Cells
1998
Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease.
1993 Standout
Prion protein (PrP) synthetic peptides induce cellular PrP to acquire properties of the scrapie isoform.
1995 StandoutNobel
Evidence for the Conformation of the Pathologic Isoform of the Prion Protein Enciphering and Propagating Prion Diversity
1996 StandoutScienceNobel
Enhanced expression of the human gene N-myc consequent to amplification of DNA may contribute to malignant progression of neuroblastoma.
1984 StandoutNobel
Predictors of Cerebral Infarction in Aneurysmal Subarachnoid Hemorrhage
2004
Prions
1998 StandoutNobel
Potential role of somatostatin analogues in the treatment of cancer
1987
Solution structure of a 142-residue recombinant prion protein corresponding to the infectious fragment of the scrapie isoform
1997 StandoutNobel
Growth Factors and Cancer
1991 StandoutScience
Cushing's syndrome
1985
Imaging and Photodynamic Therapy: Mechanisms, Monitoring, and Optimization
2010 Standout
Quantitative Imaging Study of Extent of Surgical Resection and Prognosis of Malignant Astrocytomas
1997
Embryonal central neuroepithelial tumors and their differentiating potential
1985
Transmission of Creutzfeldt-Jakob disease from humans to transgenic mice expressing chimeric human-mouse prion protein.
1994 StandoutNobel
Biogenesis of γ-secretase early in the secretory pathway
2007 StandoutNobel
EFFECT OF BROMOCRIPTINE IN PITUITARY‐DEPENDENT CUSHING'S SYNDROME
1983
Successful adjuvant-free vaccination of BALB/c mice with mutated amyloid β peptides
2008
Transsphenoidal Surgery for Cushing's Disease
1986
Early Postoperative Magnetic Resonance Imaging after Resection of Malignant Glioma
1995
High-Level Expression and Characterization of a Purified 142-Residue Polypeptide of the Prion Protein
1996 StandoutNobel
Infarction after aneurysm rupture does not depend on distribution or clearance rate of blood.
1992
Inherited prion diseases.
1994 StandoutNobel
Early Postoperative Magnetic Resonance Imaging after Resection of Malignant Glioma
1994
Human N-myc gene contributes to neoplastic transformation of mammalian cells in culture
1985 StandoutNatureNobel
Peptide Receptors as Molecular Targets for Cancer Diagnosis and Therapy
2003
Works of S Stefanko being referenced
Presenile Alzheimer dementia characterized by amyloid angiopathy and large amyloid core type senile plaques in the APP 692Ala→Gly mutation
1998
Heterogeneity of Growth Hormone (GH) Release by Individual Pituitary Adenoma Cells From Acromegalic Patients, as Determined by the Reverse Hemolytic Plaque Assay: Effects of SMS 201-995, GH-Releasing Hormone and Thyrotropin-Releasing Hormone*
1989
Cytogenetic, Molecular Genetic and Pathological Analyses in 126 Meningiomas
1995
Prognostic implications of glial fibrillary acidic protein containing cell types in oligodendrogliomas
1990
THE SENSITIVITY OF GROWTH HORMONE AND PROLACTIN SECRETION TO THE SOMATOSTATIN ANALOGUE SMS 201–995 IN PATIENTS WITH PROLACTINOMAS AND ACROMEGALY
1986
Adrenocorticotropin-Secreting Pituitary Adenomas Originate from the Anterior or the Intermediate Lobe in Cushing's Disease: Differences in the Regulation of Hormone Secretion
1982
PINEALOBLASTOMA WITH RETINOBLASTOMATOUS DIFFERENTIATION
1979
Failure of Clinical Remission after Transsphenoidal Removal of a Microadenoma in a Patient with Cushing’s Disease: Multiple Hyperplastic and Adenomatous Cell Nests in Surrounding Pituitary Tissuetitle
1980
High Incidence of Somatostatin Receptors in Human Meningiomas: Biochemical Characterization
1986
Familial Creutzfeldt-Jakob disease
1979
Delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage
1986
The influence of the extent of surgery on the neurological function and survival in malignant glioma. A retrospective analysis in 243 patients.
1990